Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis

Vulvovaginal candidiasis is the most prevalent vaginal infection worldwide and Candida albicans is its major agent. Vulvovaginal candidiasis is characterized by disruption of the vaginal microbiota composition, as happens following large spectrum antibiotic usage. Recent studies support the effectiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Virulence 2017-01, Vol.8 (1), p.74-90
Hauptverfasser:	Pericolini, Eva, Gabrielli, Elena, Ballet, Nathalie, Sabbatini, Samuele, Roselletti, Elena, Cayzeele Decherf, Amélie, Pélerin, Fanny, Luciano, Eugenio, Perito, Stefano, Jüsten, Peter, Vecchiarelli, Anna
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Aspartic Acid Proteases - antagonists & inhibitors Bacterial Adhesion Candida albicans Candida albicans - physiology Candidiasis, Vulvovaginal - microbiology Candidiasis, Vulvovaginal - therapy Epithelial Cells - microbiology Female fungi Humans Mice probiotics Probiotics - administration & dosage Probiotics - therapeutic use Research Paper Saccharomyces cerevisiae Saccharomyces cerevisiae - growth & development Saccharomyces cerevisiae - physiology therapeutic activity Vagina - microbiology vaginal candidiasis vaginal health vaginal infections Virulence Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!